This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
BioValley is a unique tri-national network of French, Swiss and German contributors, serving as a gateway to biobusiness development in Europe by bringing together and supporting the collaboration of public and private enterprises. As a board member, Mr. Meissonnier will work to support Alsace BioValley in its efforts to continue driving growth in the life sciences by identifying and coordinating ambitious projects that will create employment opportunities in the region.
“I am pleased to join a team of individuals committed to growing the life sciences in the BioValley area. It is an honor to be recognized, and at Catalent, we are passionate about innovation and growth. It is exciting to contribute to this culture within the BioValley team,” said Mr. Meissonnier.
Francois Boçquel, President of Alsace BioValley, said, “It is with enthusiasm that we welcome Julien Meissonnier to our Board of Directors. The opportunity for growth in the life sciences within this region is significant. We benefit from first-class academic research, a remarkable capacity for training and a critical mass of leading industries. Directing this organization is a tremendous responsibility and we look forward to Julien's contribution.”
At Catalent, Mr. Meissonnier provides technical and scientific leadership for the development of delivery systems for poorly soluble drugs that lead to approvable regulatory dossiers. His responsibilities include early stage screening activities, developing products, scale-up and technology transfer, directing clinical supplies and supporting product launches. Mr. Meissonnier has 12 years of experience in pharmaceutical development. He received his Engineer Degree in Physico-Chemistry from the ENSI in Caen, France.
“I am pleased to join a team of individuals committed to growing the life sciences in the BioValley area. It is an honor to be recognized, and at Catalent, we are passionate about innovation and growth. It is exciting to contribute to this culture within the BioValley team,” said Mr. Meissonnier.
Francois Boçquel, President of Alsace BioValley, said, “It is with enthusiasm that we welcome Julien Meissonnier to our Board of Directors. The opportunity for growth in the life sciences within this region is significant. We benefit from first-class academic research, a remarkable capacity for training and a critical mass of leading industries. Directing this organization is a tremendous responsibility and we look forward to Julien's contribution.”
At Catalent, Mr. Meissonnier provides technical and scientific leadership for the development of delivery systems for poorly soluble drugs that lead to approvable regulatory dossiers. His responsibilities include early stage screening activities, developing products, scale-up and technology transfer, directing clinical supplies and supporting product launches. Mr. Meissonnier has 12 years of experience in pharmaceutical development. He received his Engineer Degree in Physico-Chemistry from the ENSI in Caen, France.
Companies in this article
